VAG
ABBV icon

VisionPoint Advisory Group’s AbbVie ABBV Stock Holding History

VisionPoint Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.08M Buy
4,121
+124
+3% +$31.8K 0.17% 132
2026
Q2 		$1.01M Buy
3,997
+436
+12% +$93.8K 0.16% 143
2026
Q1 		$774K Sell
3,561
-69
-2% -$15.3K 0.15% 161
2025
Q4 		$829K Buy
3,630
+44
+1% +$10K 0.16% 144
2025
Q3 		$830K Sell
3,586
-93
-3% -$18.9K 0.17% 141
2025
Q2 		$683K Buy
3,679
+1,556
+73% +$289K 0.15% 152
2025
Q1 		$445K Buy
2,123
+473
+29% +$92K 0.15% 121
2024
Q4 		$296K Sell
1,650
-271
-14% -$49.8K 0.1% 144
2024
Q3 		$379K Sell
1,921
-546
-22% -$102K 0.13% 124
2024
Q2 		$423K Sell
2,467
-4,480
-64% -$742K 0.15% 115
2024
Q1 		$1.27M Sell
6,947
-3,311
-32% -$571K 0.46% 62
2023
Q4 		$1.59M Buy
10,258
+634
+7% +$92.4K 0.59% 50
2023
Q3 		$1.43M Buy
9,624
+201
+2% +$29.5K 0.62% 49
2023
Q2 		$1.27M Sell
9,423
-857
-8% -$126K 0.52% 56
2023
Q1 		$1.51M Sell
10,280
-3,455
-25% -$528K 0.67% 41
2022
Q4 		$2.11M Buy
13,735
+6,005
+78% +$921K 0.87% 31
2022
Q3 		$1.04M Buy
7,730
+199
+3% +$28.6K 0.5% 29
2022
Q2 		$1.07M Sell
7,531
-1,237
-14% -$189K 0.42% 39
2022
Q1 		$1.35M Buy
+8,768
New +$1.27M 0.63% 38
2021
Q1 		– Sell
-2,038
Closed -$218K – 114
2020
Q4 		$218K Sell
2,038
-5,432
-73% -$522K 0.11% 130
2020
Q3 		$654K Sell
7,470
-3,229
-30% -$304K 0.28% 49
2020
Q2 		$1.04M Buy
10,699
+7,544
+239% +$664K 0.42% 34
2020
Q1 		$240K Sell
3,155
-450
-12% -$38.3K 0.11% 96
2019
Q4 		$319K Sell
3,605
-1,026
-22% -$85.2K 0.13% 82
2019
Q3 		$346K Buy
4,631
+1,133
+32% +$77.7K 0.09% 86
2019
Q2 		$254K Buy
3,498
+40
+1% +$3.14K 0.07% 110
2019
Q1 		$279K Buy
+3,458
New +$283K 0.08% 105

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

VisionPoint Advisory Group's ABBV Position: Q3 2026 in Review

VisionPoint Advisory Group increased its AbbVie (ABBV) stake by 3.1% in Q3 2026, buying an estimated $31.8K and bringing the position to 4,121 shares worth $1.08M. The position accounts for 0.17% of the portfolio, ranked #132.

VisionPoint Advisory Group first reported a position in ABBV in Q1 2019 and has held it in 27 quarters since. The position peaked at $2.11M in Q4 2022. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • VisionPoint Advisory Group held 4,121 shares of AbbVie worth $1.08M as of Q3 2026.
  • VisionPoint Advisory Group bought 124 AbbVie shares in Q3 2026, an estimated $31.8K.
  • AbbVie made up 0.17% of VisionPoint Advisory Group's portfolio in Q3 2026, its #132 holding.
  • VisionPoint Advisory Group first reported a position in AbbVie in Q1 2019 and has held it in 27 quarters since.
  • VisionPoint Advisory Group's AbbVie position peaked at $2.11M in Q4 2022.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on VisionPoint Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.